(Q31926164)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11173177%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Tibolone: what does tissue specific activity mean? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11173177%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11173177%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Palacios S

series ordinal

1

1 reference

5 July 2017

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11173177%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11173177%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11173177%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11173177%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

159-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11173177%20AND%20SRC:MED&resulttype=core&format=json

Pharmacological studies with (7 alpha,17 alpha)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14)

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Tibolone and climacteric symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Betalipotropin and betaendorphin in physiological and surgical menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Psychological effects of hormone replacement therapy: a comparison of tibolone and a sequential estrogen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Changes in sex behaviour after menopause: effects of tibolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

A study of the effect of tibolone on the vagina in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Prevention of postmenopausal bone loss at lumbar spine and upper femur with tibolone: a two-year randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Long-term effects of Org OD 14 on lipid metabolism in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

The effect of tibolone on cardiac flow in postmenopausal women with non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Hormone replacement therapy and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Clinical experience with tibolone (Livial) over 8 years

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Mammographic changes in women receiving tibolone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Org OD 14 and the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Cause of vaginal bleeding in postmenopausal women taking tibolone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Human endometrial 3 beta-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Estradiol stimulates c-myc proto-oncogene expression in normal human breast epithelial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Effects of progestagens and Org OD14 in in vitro and in vivo tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

Effect of nomegestrol acetate on estrone-sulfatase and 17beta-hydroxysteroid dehydrogenase activities in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900184-5

7 January 2021

10.1016/S0378-5122(00)00184-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11173177%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference